Literature DB >> 3262628

Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.

G C Bagby1, C A Dinarello, R C Neerhout, D Ridgway, E McCall.   

Abstract

Marrow and peripheral blood cells from nine children with juvenile chronic granulocytic leukemia (JCGL) demonstrated intense (94 +/- 16% maximum) spontaneous granulocyte/macrophage colony growth but cells from five children with the adult variety of CGL did not. This unusual pattern of colony growth depended upon a stimulatory protein(s) produced by mononuclear phagocytes. No GM-CSA activity was found in any chromatofocused fraction of JCGL monocyte-conditioned media but an activity that induced GM-CSA in umbilical vein endothelial cells was detected at pI 6.9-7.2. Moreover, the CSA-inducing monokine was neutralized by an anti-IL-1 antibody in vitro and, in the one case so tested, the same antibody also inhibited "spontaneous" colony growth. Therefore granulocyte/macrophage colony growth in JCGL is characteristically abnormal and distinguishes JCGL from the adult form of the disease. This abnormality depends upon the production, by mononuclear phagocytes, of IL-1 which, in turn, stimulates the release of high levels of colony stimulating activity by other cells. The high proliferative activity of CFU-GM we found in JCGL patients, and the high levels of GM-CSA found in their serum are compatible with the view that the in vitro abnormality reflects a similar abnormality in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262628      PMCID: PMC442701          DOI: 10.1172/JCI113748

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  The effect of cytosine arabinoside in vitro on agar colony forming cells and spleen colony forming cells of C57BL mouse bone marrow.

Authors:  R E Millard; S F Okell
Journal:  Cell Tissue Kinet       Date:  1975-01

2.  Juvenile "chronic granulocytic" leukemia: a panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells.

Authors:  A J Altman; C G Palmer; R L Baehner
Journal:  Blood       Date:  1974-03       Impact factor: 22.113

3.  Cytogenetic features of juvenile chronic myelogenous leukemia.

Authors:  G M Brodeur; L W Dow; D L Williams
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

4.  Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro.

Authors:  G C Bagby; V D Rigas; R M Bennett; A A Vandenbark; H S Garewal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

5.  The influence of culture conditions on the production of colony-stimulating activity by human placenta.

Authors:  T Schlunk; M Schleyer
Journal:  Exp Hematol       Date:  1980-02       Impact factor: 3.084

6.  Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF.

Authors:  K M Zsebo; V N Yuschenkoff; S Schiffer; D Chang; E McCall; C A Dinarello; M A Brown; B Altrock; G C Bagby
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

7.  Juvenile and adult types of chronic granulocytic leukemia of childhood: growth patterns and characteristics of granulocyte-macrophage colony forming cells.

Authors:  Y Barak; S Levin; R Vogel; I J Cohen; B Wallach; E Nir; R Zaizov
Journal:  Am J Hematol       Date:  1981       Impact factor: 10.047

8.  In vitro colony-forming characteristics of chronic granulocytic leukemia in childhood.

Authors:  A J Altman; R L Baehner
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

9.  Juvenile chronic granulocytic leukemia: emphasis on cutaneous manifestations and underlying neurofibromatosis.

Authors:  J A Mays; R C Neerhout; G C Bagby; R D Koler
Journal:  Am J Dis Child       Date:  1980-07

10.  Human blood monocytes: stimulators of granulocyte and mononuclear colony formation in vitro.

Authors:  P A Chervenick; A F LoBuglio
Journal:  Science       Date:  1972-10-13       Impact factor: 47.728

View more
  4 in total

1.  Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression.

Authors:  M Aguilar-Santelises; R Magnusson; S B Svenson; A Loftenius; B Andersson; H Mellstedt; M Jondal
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

2.  Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects.

Authors:  Sasja Blokzijl-Franke; Florian Piques; Maja Solman; Chuan Yan; Qiqi Yang; Marion Strullu; Sarah M Kamel; Pakize Ak; Jeroen Bakkers; David M Langenau; Hélène Cavé; Jeroen den Hertog
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

3.  Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.

Authors:  Y Y Zhang; T A Vik; J W Ryder; E F Srour; T Jacks; K Shannon; D W Clapp
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

4.  FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1β in macrophages.

Authors:  Michael R Garbati; Laura E Hays; Winifred Keeble; Jane E Yates; R Keaney Rathbun; Grover C Bagby
Journal:  Blood       Date:  2013-09-17       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.